Document Detail


Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine.
MedLine Citation:
PMID:  11687866     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An 18-year-old woman with ulcerative colitis (UC) developed diffuse pulmonary infiltrates and hypoxemia three months after reinstitution of oral mesalamine. Lung biopsy revealed bronchiolitis obliterans with interstitial pneumonitis. Clinical and radiographic abnormalities improved upon discontinuation of mesalamine and treatment with corticosteroids. This patient presented the problem of differential diagnosis of pulmonary disease associated with inflammatory bowel disease (IBD), including lesions believed to result from lung involvement secondary to IBD, as well as adverse reactions to medications. We present and analyze evidence associating mesalamine with pulmonary toxicity in this patient, but emphasize that the distinction between adverse drug reaction and extraintestinal manifestations of IBD is difficult.
Authors:
G Haralambou; A S Teirstein; J Gil; D H Present
Related Documents :
12724846 - Inducing remission in inflammatory bowel disease.
16733856 - Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: respon...
344126 - Protective effect of metronidazole in experimental ulcerative colitis.
20485256 - Surveillance strategies in inflammatory bowel disease.
20959326 - State-of-the-art: rheumatoid arthritis.
7257746 - Hereditary diseases of the eye in a study of blind and partially sighted.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Mount Sinai journal of medicine, New York     Volume:  68     ISSN:  0027-2507     ISO Abbreviation:  Mt. Sinai J. Med.     Publication Date:  2001 Nov 
Date Detail:
Created Date:  2001-11-05     Completed Date:  2001-12-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0241032     Medline TA:  Mt Sinai J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  384-8     Citation Subset:  IM    
Affiliation:
Division of Pulmonary and Critical Care Medicine, Mount Sinai School of Medicine, New York, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Bronchiolitis Obliterans / etiology*,  pathology,  radiography
Colitis, Ulcerative / complications,  drug therapy*
Female
Humans
Mesalamine / therapeutic use*
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 89-57-6/Mesalamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Moses presages Kubler-Ross: five stages in accepting death, as seen in the midrash.
Next Document:  Can a drug-induced pulmonary hypersensitivity reaction be dose-dependent? A case with mesalamine.